Hair Dye and Chemical Straightener Use and Breast Cancer Risk in a Large US Population of Black and White Women
Overview
Affiliations
Many hair products contain endocrine-disrupting compounds and carcinogens potentially relevant to breast cancer. Products used predominately by black women may contain more hormonally-active compounds. In a national prospective cohort study, we examined the association between hair dye and chemical relaxer/straightener use and breast cancer risk by ethnicity. Sister Study participants (n = 46,709), women ages 35-74, were enrolled between 2003 and 2009, and had a sister with breast cancer but were breast cancer-free themselves. Enrollment questionnaires included past 12-month hair product use. Cox proportional hazards models estimated adjusted hazard ratios (HRs) and 95% confidence intervals (95% CIs) for the association between hair products and breast cancer; effect measure modification by ethnicity was evaluated. During follow-up (mean = 8.3 years), 2,794 breast cancers were identified. Fifty-five percent of participants reported using permanent dye at enrollment. Permanent dye use was associated with 45% higher breast cancer risk in black women (HR = 1.45, 95% CI: 1.10-1.90), and 7% higher risk in white women (HR = 1.07, 95% CI: 0.99-1.16; heterogeneity p = 0.04). Among all participants, personal straightener use was associated with breast cancer risk (HR = 1.18, 95% CI 0.99-1.41); with higher risk associated with increased frequency (p for trend = 0.02). Nonprofessional application of semipermanent dye (HR = 1.28, 95% CI 1.05-1.56) and straighteners (HR = 1.27, 95% CI 0.99-1.62) to others was associated with breast cancer risk. We observed a higher breast cancer risk associated with any straightener use and personal use of permanent dye, especially among black women. These results suggest that chemicals in hair products may play a role in breast carcinogenesis.
Shareef J, Sridhar S, Sherin S, Abdul Nazat S Turk J Pharm Sci. 2025; 21(6):506-512.
PMID: 39801004 PMC: 11730004. DOI: 10.4274/tjps.galenos.2024.33489.
Llanos A, Ashrafi A, Olisa T, Rockson A, Schaefer A, McDonald J Int J Environ Res Public Health. 2024; 21(7).
PMID: 39063423 PMC: 11277196. DOI: 10.3390/ijerph21070846.
Taylor K, Co C, Gaston S, Jackson C, Harmon Q, Baird D J Expo Sci Environ Epidemiol. 2024; 34(4):659-669.
PMID: 38811800 PMC: 11303245. DOI: 10.1038/s41370-024-00690-x.
Schildroth S, Geller R, Wesselink A, Lovett S, Bethea T, Claus Henn B Chemosphere. 2024; 361:142442.
PMID: 38810806 PMC: 11217908. DOI: 10.1016/j.chemosphere.2024.142442.
Smarr M, Avakian M, Lopez A, Onyango B, Amolegbe S, Boyles A Environ Health Perspect. 2024; 132(1):15002.
PMID: 38227347 PMC: 10790815. DOI: 10.1289/EHP12996.